#LifeScienceRevolution: Proximity to Resources with KaloCyte – Part 3 of 4
In this episode, Marty discusses business in Maryland with Elaine Haynes, President and CEO of KaloCyte, a pre-clinical biotech startup developing a synthetic red blood cell substitute.
#LifeScienceRevolution: Proximity to Resources with KaloCyte – Part 3 of 4
In this episode, Marty discusses business in Maryland with Elaine Haynes, President and CEO of KaloCyte, a pre-clinical biotech startup developing a synthetic red blood cell substitute.